In 11 out of 12 EBV+ GCs, PD-L1+ immune cells were observed to infiltrate the tumor (TI), while in 4/5 PD-L1+/EBV negative GCs, PD-L1+ immune cells stayed at the invasive margin (IM) (Figure 1C–1E). Here, CD274 is linked to neoplasm.